Live feed
Filing
SC 13D/A
SC 13D/A0001193125-22-215737·Landos Biopharma, Inc.
Schedule 13D ownership disclosure
Landos Biopharma, Inc.
Security class unavailable · CUSIP: 515069102
Event date: 2022-08-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-215737
- Form type
- SC 13D/A
- Filer
- Landos Biopharma, Inc.
- CIK
- CIK 1785345
- Filed
- Aug 09, 2022
- Reporting period
- Aug 09, 2022
- Description
- Schedule 13D beneficial ownership